Signoretti S - Search Results

1

Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy.

Sabir A, Schor-Bardach R, Wilcox CJ, Rahmanuddin S, Atkins MB, Kruskal JB, Signoretti S, Raptopoulos VD, Goldberg SN. Sabir A, et al. Among authors: signoretti s. AJR Am J Roentgenol. 2008 Jul;191(1):133-9. doi: 10.2214/AJR.07.2848. AJR Am J Roentgenol. 2008. PMID: 18562736

2

Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model.

Horkan C, Dalal K, Coderre JA, Kiger JL, Dupuy DE, Signoretti S, Halpern EF, Goldberg SN. Horkan C, et al. Among authors: signoretti s. Radiology. 2005 Apr;235(1):81-8. doi: 10.1148/radiol.2351040269. Epub 2005 Feb 24. Radiology. 2005. PMID: 15731375

3

Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.

Ahmed M, Liu Z, Lukyanov AN, Signoretti S, Horkan C, Monsky WL, Torchilin VP, Goldberg SN. Ahmed M, et al. Among authors: signoretti s. Radiology. 2005 May;235(2):469-77. doi: 10.1148/radiol.2352031856. Radiology. 2005. PMID: 15858089

4

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

Atkins M, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Febbo P, Upton M, Lechpammer M, Signoretti S. Atkins M, et al. Among authors: signoretti s. Clin Cancer Res. 2005 May 15;11(10):3714-21. doi: 10.1158/1078-0432.CCR-04-2019. Clin Cancer Res. 2005. PMID: 15897568

5

Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.

Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN. Hines-Peralta A, et al. Among authors: signoretti s. Radiology. 2006 Jul;240(1):82-9. doi: 10.1148/radiol.2401050788. Epub 2006 May 23. Radiology. 2006. PMID: 16720872

6

The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer.

Cho D, Signoretti S, Regan M, Mier JW, Atkins MB. Cho D, et al. Among authors: signoretti s. Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):758s-763s. doi: 10.1158/1078-0432.CCR-06-1986. Clin Cancer Res. 2007. PMID: 17255306 Review.

7

Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice.

Hakimé A, Hines-Peralta A, Peddi H, Atkins MB, Sukhatme VP, Signoretti S, Regan M, Goldberg SN. Hakimé A, et al. Among authors: signoretti s. Radiology. 2007 Aug;244(2):464-70. doi: 10.1148/radiol.2442061005. Radiology. 2007. PMID: 17641366

8

Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma.

Cho D, Signoretti S, Dabora S, Regan M, Seeley A, Mariotti M, Youmans A, Polivy A, Mandato L, McDermott D, Stanbridge E, Atkins M. Cho D, et al. Among authors: signoretti s. Clin Genitourin Cancer. 2007 Sep;5(6):379-85. doi: 10.3816/CGC.2007.n.020. Clin Genitourin Cancer. 2007. PMID: 17956710

9

Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.

Signoretti S, Regan M, Atkins M. Signoretti S, et al. BJU Int. 2008 Jun;101 Suppl 4:31-5. doi: 10.1111/j.1464-410X.2008.07646.x. BJU Int. 2008. PMID: 18430120 Review. No abstract available.

10

Tissue-based research in kidney cancer: current challenges and future directions.

Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB. Signoretti S, et al. Clin Cancer Res. 2008 Jun 15;14(12):3699-705. doi: 10.1158/1078-0432.CCR-07-4733. Clin Cancer Res. 2008. PMID: 18559586 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page